These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 11773861
1. Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients. Marchal-Victorion S, Vionnet N, Escrieut C, Dematos F, Dina C, Dufresne M, Vaysse N, Pradayrol L, Froguel P, Fourmy D. Pharmacogenetics; 2002 Jan; 12(1):23-30. PubMed ID: 11773861 [Abstract] [Full Text] [Related]
2. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD. Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537 [Abstract] [Full Text] [Related]
9. Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies. Galés C, Poirot M, Taillefer J, Maigret B, Martinez J, Moroder L, Escrieut C, Pradayrol L, Fourmy D, Silvente-Poirot S. Mol Pharmacol; 2003 May; 63(5):973-82. PubMed ID: 12695525 [Abstract] [Full Text] [Related]
10. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin. Foucaud M, Archer-Lahlou E, Marco E, Tikhonova IG, Maigret B, Escrieut C, Langer I, Fourmy D. Regul Pept; 2008 Jan 10; 145(1-3):17-23. PubMed ID: 17961734 [Abstract] [Full Text] [Related]
11. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists. Bläker M, Ren Y, Gordon MC, Hsu JE, Beinborn M, Kopin AS. Mol Pharmacol; 1998 Nov 10; 54(5):857-63. PubMed ID: 9804620 [Abstract] [Full Text] [Related]
12. Further evidence that the CCK2 receptor is coupled to two transduction pathways using site-directed mutagenesis. Pommier B, Marie-Claire C, Da Nascimento S, Wang HL, Roques BP, Noble F. J Neurochem; 2003 Apr 10; 85(2):454-61. PubMed ID: 12675921 [Abstract] [Full Text] [Related]
16. Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptor. Archer-Lahlou E, Escrieut C, Clerc P, Martinez J, Moroder L, Logsdon C, Kopin A, Seva C, Dufresne M, Pradayrol L, Maigret B, Fourmy D. J Biol Chem; 2005 Mar 18; 280(11):10664-74. PubMed ID: 15632187 [Abstract] [Full Text] [Related]
17. Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Berna MJ, Jensen RT. Curr Top Med Chem; 2007 Mar 18; 7(12):1211-31. PubMed ID: 17584143 [Abstract] [Full Text] [Related]
18. Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor. Silvente-Poirot S, Escrieut C, Galès C, Fehrentz JA, Escherich A, Wank SA, Martinez J, Moroder L, Maigret B, Bouisson M, Vaysse N, Fourmy D. J Biol Chem; 1999 Aug 13; 274(33):23191-7. PubMed ID: 10438490 [Abstract] [Full Text] [Related]
20. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors. Wang HL. J Neurochem; 1997 Apr 13; 68(4):1728-35. PubMed ID: 9084447 [Abstract] [Full Text] [Related] Page: [Next] [New Search]